Rhenman & Partners Asset Management’s Loxo Oncology, Inc LOXO Stock Holding History

Rhenman & Partners Asset Management’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-10,000	Closed	-$1.4M	–	101
2018 Q4	$1.4M	Sell	10,000 -40,000	-80%	-$6.07M	0.16%	68
2018 Q3	$8.54M	Sell	50,000 -72,961	-59%	-$12.3M	0.86%	51
2018 Q2	$21.3M	Buy	122,961 +47,961	+64%	+$7.21M	2.18%	16
2018 Q1	$8.65M	Sell	75,000 -15,280	-17%	-$1.63M	1.07%	42
2017 Q4	$7.6M	Buy	90,280 +15,280	+20%	+$1.27M	1.03%	37
2017 Q3	$6.91M	Buy	+75,000	New	+$5.83M	0.88%	43

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Rhenman & Partners Asset Management's LOXO Position: Q1 2019 in Review

Rhenman & Partners Asset Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 10,000 shares — an estimated $1.4M sold.

Rhenman & Partners Asset Management first reported a position in LOXO in Q3 2017 and held it in 6 quarters. The position peaked at $21.3M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Rhenman & Partners Asset Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Rhenman & Partners Asset Management sold 10,000 Loxo Oncology, Inc shares in Q1 2019, an estimated $1.4M.
Rhenman & Partners Asset Management first reported a position in Loxo Oncology, Inc in Q3 2017 and held it in 6 quarters.
Rhenman & Partners Asset Management's Loxo Oncology, Inc position peaked at $21.3M in Q2 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Rhenman & Partners Asset Management's 13F filing for Q1 2019, filed 11 Apr 2019.